Who is sponsoring NCT02499666?

NCT02499666 is sponsored by Henry Ford Health System.

What drugs are being tested in NCT02499666?

Interventions in NCT02499666: Percutaneous Coronary Intervention, Coronary stent, Clopidogrel.

What condition does NCT02499666 study?

NCT02499666 studies Coronary Artery Disease, Angina Pectoris.

Is NCT02499666 still recruiting?

NCT02499666 is currently terminated. Last updated 7 March 2022.

Last reviewed 2022-03-07 · How we verify

NCT02499666: EXERTION

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Change in Exercise Capacity as Measured by Peak Oxygen Uptake After CTO PCI

Terminated Last updated 7 March 2022

What this trial tests

trial testing Percutaneous Coronary Intervention in Coronary Artery Disease in 15 participants. Terminated before completion.

Timeline

29 June 2015

Primary endpoint
30 October 2017

30 October 2017

Quick facts

Lead sponsor	Henry Ford Health System
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	15
Start date	29 June 2015
Primary completion	30 October 2017
Estimated completion	30 October 2017
Sites	1 location across United States

Drugs / interventions tested

Percutaneous Coronary Intervention
Coronary stent
Clopidogrel (clopidogrel) — full drug profile →

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →
Angina Pectoris — all drugs for Angina Pectoris →

Sponsor

Henry Ford Health System — full company profile →

Who can join

Adults 18 to 90, any sex, with Coronary Artery Disease or Angina Pectoris. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this project is to objectively assess the change (improvement) in exercise capacity in patients undergoing routine percutaneous coronary intervention (PCI) for chronic total occlusion (CTO)

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Percutaneous Coronary Intervention

Trials testing the same drug.

NCT07373678 — CABG Versus PCI in Patients With Isolated LAD Chronic Total Occlusion · completed
NCT07303439 — Randomised Trial of Dual Device Treatment Involving Drug-coated Balloon Angioplasty and Drug-eluting Stent Implantation · NA · recruiting
NCT07034157 — A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Cor · recruiting
NCT06654453 — The Thrombus Aspiration During PCI After Thrombolysis in STEMI · NA · recruiting
NCT06779110 — Intracoronary Optical Coherence Tomography Guidance Vs. Angiography Only Guidance for Treatment of Coronary In-stent Res · NA · recruiting

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Henry Ford Health System trials

Trials by the same sponsor.

NCT07450183 — Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1 · Phase 2 · not yet recruiting
NCT07418853 — Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries · NA · not yet recruiting
NCT06670287 — The Use of Multiple Sensors to Track Sleep in Nightshift Workers · NA · recruiting
NCT07363525 — Michigan Initial Experience Using Tigertriever for Thrombectomy · not yet recruiting
NCT07530172 — Radioembolization Versus External Radiation Therapy · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02499666 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Henry Ford Health System
Last refreshed: 7 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02499666.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing